GAMAMABS PHARMA

gamamabs-pharma-logo

GamaMabs is a privately held immuno-oncology biotechnology company specialized in the development of optimized monoclonal antibodies (mAb). Its lead program is GM102 (formerly 3C23K), a mAb targeting the receptor of the anti-Müllerian hormone (AMHR2) in gynecological cancers, currently in phase Ia/Ib stage. GM102 has increased tumor cell killing properties through the activation of immune system cells, thanks to its EMABling® glyco-engineering technology. Founded in June 2013 in Toulouse (Fr... ance), GamaMabs employs 7 professionals with a sound and successful experience in preclinical and clinical development up to registration. GamaMabs has established collaborations with leading academic and private partners in order to develop its programs, such as Institut Gustave Roussy, Institut Curie, Institut Cochin, Institut de Recherche en Cancérologie de Montpellier (IRCM) or Mass General Hospital (Boston). GamaMabs values high-potential technologies initially developed by LFB BIOTECHNOLOGIES, a French Biopharma specialized in Hemostasis and Immunological Disorders. LFB developed two original patented platforms for the generation of mAbs with high efficiency (EMABling®) and/or long duration of action (HuMabFc), as well as a pipeline of several products stemming from those technologies. For strategic reason LFB decided to transfer some assets and rights to use its mAbs platforms and mAbs Oncology projects to GamaMabs. The main objective of GamaMabs is to develop its mAbs up to the stage of Clinical Proof of Concept.

#SimilarOrganizations #People #Financial #Website #More

GAMAMABS PHARMA

Industry:
Biotechnology Health Care Therapeutics

Founded:
2013-01-01

Address:
Toulouse, Midi-Pyrenees, France

Country:
France

Website Url:
http://www.gamamabs.com

Total Employee:
1+

Status:
Active

Contact:
+33 (0)5 31 61 60 69

Email Addresses:
[email protected]

Total Funding:
18.1 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt WordPress Apache Wordpress Plugins Google Maps PHP Google Maps API OVH


Similar Organizations

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.


Current Advisors List

françois-thomas_image

François Thomas Member of the Board of Directors @ GamaMabs Pharma
Board_member

Current Employees Featured

jean-francois-prost_image

Jean-Francois Prost
Jean-Francois Prost Chief Medical and Scientific Officer @ GamaMabs Pharma
Chief Medical and Scientific Officer
2012-01-01

jean-francois-prost_image

Jean-Francois Prost
Jean-Francois Prost VP R&D and strategy @ GamaMabs Pharma
VP R&D and strategy

Founder


stephane-degove_image

Stephane Degove

Investors List

edmond-de-rothschild-investment-partners_image

Andera Partners

Andera Partners investment in Series B - GamaMabs Pharma

bpifrance_image

Bpifrance

Bpifrance investment in Series A - GamaMabs Pharma

Official Site Inspections

http://www.gamamabs.com

  • Host name: 104.21.31.200
  • IP address: 104.21.31.200
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "GamaMabs Pharma" on Search Engine